Given the significant overlap in clinical presentation, individuals with a strong family history of AD should also be screened for mutations in MAPT and GRN, genes typically associated with frontotemporal lobar degeneration, when no autopsy is available. This evidence concerns the gene GRN and Alzheimer disease.